---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-23-000087"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2023-04-18T23:59:59+00:00"
generated_at: "2026-06-17T00:23:13.142380+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Intuitive Surgical Q1 revenue $1.70B (+14% YoY), da Vinci procedures +26%, non-GAAP EPS $1.23

## Summary
- Revenue $1.70B, up 14% YoY; constant currency growth of 17%.
- GAAP diluted EPS $1.00 (flat); non-GAAP diluted EPS $1.23 vs $1.13.
- da Vinci procedure volume grew ~26% YoY; placed 312 systems; installed base 7,779 (+12%).
- Instruments & accessories revenue $986M (+22%); systems revenue $427M (flat).
- European certification for Ion endoluminal system obtained; initial focus on UK market.

## SEC filing metadata
- accession: 0001035267-23-000087
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2023-04-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526723000087/0001035267-23-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526723000087/isrg-20230418.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-23-000087
- JSON: https://secwatch.observer/filing/0001035267-23-000087.json
- Plain text: https://secwatch.observer/filing/0001035267-23-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.